Company Overview - 加和国际控股有限公司 is a contract manufacturer based in Singapore, specializing in the production and sale of disposable medical devices and injection-molded plastic components, as well as providing mold-making services [2] - Established in 1981, the company has become a reliable contract manufacturer for major international healthcare and medical device companies [2] - The company's revenue is derived from two main segments: manufacturing and selling disposable medical device components, and providing mold-making services [2] Financial Performance - As of December 31, 2024, 加和国际控股 reported total revenue of 55.6565 million yuan, representing a year-on-year growth of 14.33% [1] - The company recorded a net profit attributable to shareholders of -14.0006 million yuan, showing a year-on-year increase of 61% [1] - The gross profit margin stood at 2.18%, while the debt-to-asset ratio was 75.71% [1] Market Position and Valuation - 加和国际控股's price-to-earnings (P/E) ratio is -6.88, ranking 85th in the industry, compared to the average P/E ratio of -2.68 for the healthcare equipment and services sector [1] - The company has experienced a cumulative decline of 11.19% over the past month and a 28.25% decline year-to-date, underperforming the Hang Seng Index, which has risen by 19.78% [1] - Currently, there are no investment rating recommendations from institutions for 加和国际控股 [1] Industry Context - The healthcare equipment and services industry has an average P/E ratio of -2.68, with a median of 1.17 [1] - Other companies in the industry include 巨星医疗控股 (02393.HK) with a P/E of 0.28, 京玖康疗 (00648.HK) at 0.38, 医汇集团 (08161.HK) at 1.96, 环球医疗 (02666.HK) at 5.24, and 瑞慈医疗 (01526.HK) at 5.4 [1]
加和国际控股（08513.HK）7月11日收盘上涨11.81%，成交1.4万港元